Robert A Fletcher

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Atrial Fibrillation

Systematic Review

Chronic Kidney Disease

Top Venues

Clinical journal of the American Society of Nephrology : CJASN

Journal of the American Society of Nephrology : JASN

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Robert A Fletcher, William G Herrington, Rajiv Agarwal, Kaitlin J Mayne, Clare Arnott, Meg J Jardine, Kenneth W Mahaffey, Vlado Perkovic, Natalie Staplin, David Collins Wheeler, Glenn M Chertow, Hiddo J Lambers Heerspink, Brendon L Neuen
Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials. Clinical journal of the American Society of Nephrology : CJASN (2024)
Brendon L Neuen, Robert A Fletcher, Lauren Heath, Adam Perkovic, Muthiah Vaduganathan, Sunil V Badve, Katherine R Tuttle, Richard E Pratley, Ulagamadesan Venkatesan, Vlado Perkovic, Hiddo J Lambers Heerspink
Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Circulation (2024)
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian Lee Claggett, Robert A Fletcher, William G Herrington, Catherine M Viscoli, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John Joseph Valentine McMurray, Bruce C Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David Collins Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J Lambers Heerspink, Marc S Sabatine, Stephen D Wiviott
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation 149 (23) (2024)
Robert A Fletcher, William G Herrington, Rajiv Agarwal, Kaitlin J Mayne, Clare Arnott, Meg J Jardine, Kenneth W Mahaffey, Vlado Perkovic, Natalie Staplin, David Collins Wheeler, Glenn M Chertow, Hiddo J Lambers Heerspink, Brendon L Neuen
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials. Clinical journal of the American Society of Nephrology : CJASN (2024)
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian Lee Claggett, Robert A Fletcher, William G Herrington, Catherine M Viscoli, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John Joseph Valentine McMurray, Bruce C Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David Collins Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J Lambers Heerspink, Marc S Sabatine, Stephen D Wiviott
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation (2024)
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian Lee Claggett, Robert A Fletcher, William G Herrington, Catherine M Viscoli, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John Joseph Valentine McMurray, Bruce C Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David Collins Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J Lambers Heerspink, Marc S Sabatine, Stephen D Wiviott
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation 149 (23) (2024)
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian Lee Claggett, Robert A Fletcher, William G Herrington, Catherine M Viscoli, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John Joseph Valentine McMurray, Bruce C Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David Collins Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J Lambers Heerspink, Marc S Sabatine, Stephen D Wiviott
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation 149 (23) (2024)
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian Lee Claggett, Robert A Fletcher, William G Herrington, Catherine M Viscoli, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John Joseph Valentine McMurray, Bruce C Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David Collins Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J Lambers Heerspink, Marc S Sabatine, Stephen D Wiviott
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation (2024)
Siddharth M Patel, Yu Mi Kang, KyungAh Im, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt, Javed Butler, David Z I Cherney, Brian Lee Claggett, Robert A Fletcher, William G Herrington, Catherine M Viscoli, Meg J Jardine, Kenneth W Mahaffey, Darren K McGuire, John Joseph Valentine McMurray, Bruce C Neal, Milton Packer, Vlado Perkovic, Scott D Solomon, Natalie Staplin, Muthiah Vaduganathan, Christoph Wanner, David Collins Wheeler, Faiez Zannad, Yujie Zhao, Hiddo J Lambers Heerspink, Marc S Sabatine, Stephen D Wiviott
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation 149 (23) (2024)
Robert A Fletcher, Clare Arnott, Patrick Rockenschaub, Aletta Elisabeth Schutte, Lewis Carpenter, Muthiah Vaduganathan, Rajiv Agarwal, George L Bakris, Tara I-Hsin Chang, Hiddo J Lambers Heerspink, Meg J Jardine, Kenneth W Mahaffey, Bruce C Neal, Carol A Pollock, Min Jun, Anthony Rodgers, Vlado Perkovic, Brendon L Neuen
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials. Journal of the American Heart Association (2023)
Abhinav Sharma, Pedro Marques, Brendon L Neuen, Robert A Fletcher, April E Hebert, Wally Rapattoni, Fernando G Ang, Clare Arnott, Adeera Levin, Subodh Verma, Vlado Perkovic, Kenneth W Mahaffey
Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial. Diabetes, obesity & metabolism (2023)
Brendon L Neuen, Hiddo J Lambers Heerspink, Priya Vart, Brian Lee Claggett, Robert A Fletcher, Clare Arnott, Juliana de Oliveira Costa, Michael O Falster, Sallie-Anne Pearson, Kenneth W Mahaffey, Bruce C Neal, Rajiv Agarwal, George L Bakris, Vlado Perkovic, Scott D Solomon, Muthiah Vaduganathan
Estimated Lifetime Cardiovascular, Kidney and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Non-steroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria. Circulation (2023)
Robert A Fletcher, Niels Jongs, Glenn M Chertow, John Joseph Valentine McMurray, Clare Arnott, Meg J Jardine, Kenneth W Mahaffey, Vlado Perkovic, Patrick Rockenschaub, Ellen Burgess, Ricardo Correa-Rotter, Robert D Toto, Muthiah Vaduganathan, David Collins Wheeler, Hiddo J Lambers Heerspink, Brendon L Neuen
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials. Journal of the American Society of Nephrology : JASN (2023)